• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

佩罗尼氏病中的人类白细胞抗原

HLA antigens in Peyronie's disease.

作者信息

Rompel R, Mueller-Eckhardt G, Schroeder-Printzen I, Weidner W

机构信息

Department of Dermatology, University of Giessen, FRG.

出版信息

Urol Int. 1994;52(1):34-7. doi: 10.1159/000282566.

DOI:10.1159/000282566
PMID:8140677
Abstract

This study presents data on HLA phenotypes of 52 unrelated patients suffering from idiopathic Peyronie's disease. This first investigation on HLA class II antigens detected an association of HLA-DR3 and -DQw2 in this disorder. HLA typing was done from ACD-stabilized peripheral blood using the modified lymphocytotoxicity test. Antigen frequencies of the patient group were compared with those of healthy individuals of the local population. There were no deviations of frequencies for antigens of the B7 cross-reacting group as described in earlier studies. In addition none of the other class I antigens (HLA-A, -B, -C) showed any significant deviation in frequencies after correction of p values. Regarding class II antigens HLA-DR3 was detected in the patient group in 33.3% compared with 16.0% of the control population (corrected p < 0.05). The closely linked antigen DQw2 was found in 58.8 compared with 31.2% (corrected p < 0.005). Not only genetic factors can be stated by these findings. As HLA-DR3 and -DQw2 are known to be the typical associated antigens of organospecific autoimmune disorders, this suggests possible autoimmunological factors in this disorder of otherwise unknown etiology.

摘要

本研究展示了52例患特发性佩罗尼氏病的非亲属患者的HLA表型数据。这项关于HLA - II类抗原的首次调查发现该疾病与HLA - DR3和 - DQw2存在关联。使用改良淋巴细胞毒性试验对ACD稳定的外周血进行HLA分型。将患者组的抗原频率与当地健康人群的抗原频率进行比较。如早期研究所述,B7交叉反应组的抗原频率没有偏差。此外,在对p值进行校正后,其他I类抗原(HLA - A、 - B、 - C)的频率均未显示出任何显著偏差。关于II类抗原,患者组中检测到HLA - DR3的比例为33.3%,而对照组为16.0%(校正后p < 0.05)。紧密连锁的抗原DQw2在患者组中的发现比例为58.8%,而对照组为31.2%(校正后p < 0.005)。这些发现不仅说明了遗传因素。由于已知HLA - DR3和 - DQw2是器官特异性自身免疫性疾病的典型相关抗原,这表明在这种病因不明的疾病中可能存在自身免疫因素。

相似文献

1
HLA antigens in Peyronie's disease.佩罗尼氏病中的人类白细胞抗原
Urol Int. 1994;52(1):34-7. doi: 10.1159/000282566.
2
HLA association of idiopathic Peyronie's disease: an indication of autoimmune phenomena in etiopathogenesis?特发性佩罗尼氏病与人类白细胞抗原的关联:病因发病机制中自身免疫现象的一个指征?
Tissue Antigens. 1991 Sep;38(3):104-6. doi: 10.1111/j.1399-0039.1991.tb02021.x.
3
Is there an immunogenetic basis for Peyronie's disease?
J Urol. 1997 Jan;157(1):295-7.
4
Non-association of Peyronie's disease with HLA B7 cross-reactive antigens.佩罗尼氏病与HLA B7交叉反应抗原无关联。
J Urol. 1982 Jun;127(6):1223-4. doi: 10.1016/s0022-5347(17)54302-5.
5
The genetic and bacteriological aspects of Peyronie's disease.佩罗尼氏病的遗传学和细菌学方面
J Urol. 1997 Jan;157(1):291-4.
6
Identification of an inherited form of Peyronie's disease with autosomal dominant inheritance and association with Dupuytren's contracture and histocompatibility B7 cross-reacting antigens.一种具有常染色体显性遗传的佩罗尼氏病遗传形式的鉴定及其与掌腱膜挛缩症和组织相容性B7交叉反应抗原的关联。
J Urol. 1982 Jul;128(1):48-51. doi: 10.1016/s0022-5347(17)52751-2.
7
Peyronie's disease is associated with an HLA class II antigen, HLA-DQ5, implying an autoimmune etiology.
J Urol. 1996 Oct;156(4):1330-4.
8
Prospective analysis of HLA classes I and II antigen frequency in patients with Peyronie's disease.
J Urol. 2003 Oct;170(4 Pt 1):1443-6. doi: 10.1097/01.ju.0000076488.89748.e1.
9
Peyronie's disease: a newly recognized autosomal-dominant trait.佩罗尼氏病:一种新发现的常染色体显性性状。
Am J Med Genet. 1982 Jun;12(2):227-35. doi: 10.1002/ajmg.1320120213.
10
The association of Peyronie's disease with HLA B7 cross-reactive antigens. A case report of identical twins.佩罗尼氏病与HLA B7交叉反应抗原的关联。一对同卵双胞胎的病例报告。
Cleve Clin J Med. 1987 Sep-Oct;54(5):427-30. doi: 10.3949/ccjm.54.5.427.

引用本文的文献

1
Oxidative Mechanism of Peyronie's Disease and Effectiveness of Pentoxifylline in the Therapeutic Management: A Narrative Review.佩罗尼氏病的氧化机制及己酮可可碱在治疗管理中的有效性:一项叙述性综述。
Antioxidants (Basel). 2025 Feb 12;14(2):208. doi: 10.3390/antiox14020208.
2
Role of Oxidative Stress in Peyronie's Disease: Biochemical Evidence and Experiences of Treatment with Antioxidants.氧化应激在佩罗尼病中的作用:生化证据和抗氧化剂治疗的经验。
Int J Mol Sci. 2022 Dec 15;23(24):15969. doi: 10.3390/ijms232415969.
3
Rationale of combination therapy with antioxidants in medical management of Peyronie's disease: results of clinical application.
佩罗尼氏病医学治疗中抗氧化剂联合治疗的原理:临床应用结果
Res Rep Urol. 2017 Jul 20;9:129-139. doi: 10.2147/RRU.S141748. eCollection 2017.
4
Recent Pathophysiological Aspects of Peyronie's Disease: Role of Free Radicals, Rationale, and Therapeutic Implications for Antioxidant Treatment-Literature Review.佩罗尼氏病的近期病理生理学研究进展:自由基的作用、理论依据及抗氧化治疗的临床意义——文献综述
Adv Urol. 2017;2017:4653512. doi: 10.1155/2017/4653512. Epub 2017 Jul 4.
5
Peyronie's disease: a literature review on epidemiology, genetics, pathophysiology, diagnosis and work-up.佩罗尼氏病:关于流行病学、遗传学、病理生理学、诊断及检查的文献综述
Transl Androl Urol. 2016 Jun;5(3):280-9. doi: 10.21037/tau.2016.04.05.
6
Tunica albuginea allograft: a new model of LaPeyronie's disease with penile curvature and subtunical ossification.白膜同种异体移植:一种伴有阴茎弯曲和白膜下骨化的佩罗尼氏病新模型。
Asian J Androl. 2014 Jul-Aug;16(4):592-6. doi: 10.4103/1008-682X.125900.
7
New discoveries in the basic science understanding of Peyronie's disease.佩罗尼氏病基础科学认识方面的新发现。
Curr Urol Rep. 2004 Dec;5(6):478-84. doi: 10.1007/s11934-004-0074-y.